US Patent Issued to UNIVERSITE CLAUDE BERNARD LYON 1, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), UNIVERSITE LAVAL, ECOLE NORMALE SUPERIEURE DE LYON on Oct. 14 for "Combination of diltiazem and viral polymerase inhibitors" (French, Canadian Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,440,498, issued on Oct. 14, was assigned to UNIVERSITE CLAUDE BERNARD LYON 1 (Villeurbanne, France), INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (Paris), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (Paris), UNIVERSITE LAVAL (Quebec, Canada) and ECOLE NORMALE SUPERIEURE DE LYON (Lyons, France).

"Combination of diltiazem and viral polymerase inhibitors" was invented by Olivier Terrier (Lyons, France), Manuel Rosa-Calatrava (Lyons, France), Guy Boivin (Quebec, Canada), Mario-Andres Pizzorno (Lyons, France) and Blandine Padey (Lyons, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to a combination o...